How AI and a Menopause Drug Could Revolutionize Breast Cancer Prevention - Fempower Health | A Women's Health Podcast

Episode Summary: Breast Cancer Prevention Just Took Two Big Steps ForwardIn this short but powerful episode, Georgie breaks down two groundbreaking developments in breast cancer prevention that could reshape how we think about screening, menopause care, and early intervention:1️⃣ An FDA-authorized AI tool—Clairity Breast—that predicts a woman’s five-year breast cancer risk from a standard mammogram, even when it appears normal.2️⃣ A menopause drug, Duavee, that may help prevent invasive breast cancer in women with a history of high-risk lesions like DCIS.These tools aren’t just high-tech—they’re practical, accessible, and represent a smarter, more equitable approach to women’s health.Whether you're a clinician, policymaker, or woman navigating your own care, this episode breaks down what you need to know.🔍 What You'll Learn in This Episode✅ FDA-Approved AI for Breast Cancer Risk PredictionWhat Clairity Breast is and how it worksWhy it matters for women under 50How it fits into current mammogram workflowsTimeline for rollout and insurance coverage considerations✅ Menopause Drug Duavee and Breast Cancer PreventionNew clinical trial results shared at the ASCO 2025 meetingWhy this treatment could benefit women with DCIS or other precancerous lesionsWhat clinicians and high-risk patients should be asking nowDuavee’s current FDA status and reimbursement landscape✅ The Bigger Picture: Why This Is a Turning Point in Women's HealthWhat these two tools signal about the future of precision and preventionHow they're designed to work in real-world care—not just research labsWhy this episode matters for people advocating for smarter, faster, fairer care🎯 Who This Episode Is ForWomen navigating breast cancer risk or menopause decisionsClinicians, radiologists, and OB-GYNs focused on patient-centered careHealthcare innovators, startup leaders, and payers interested in smarter early interventionPolicy leaders and health equity advocates📌 Resources & ReferencesRead about Clairity Breast – FDA De Novo authorization detailsLearn about Duavee – Clinical trial results presented at ASCO 2025Check out the blog post of this episode: Breast Cancer Prevention Just Leveled Up: What Two Breakthroughs Mean for the Future of Women’s Health📣 Help Spread the WordIf this episode helped you understand the future of breast cancer prevention, share it with a friend or clinician who needs to hear it.🎧 Loved the episode? Here's how you can take action:1. Help others discover Fempower Health:Leave a quick review on Apple or Spotify. It’s the easiest way to support our mission and amplify women’s health voices.2. Stay connected:Follow us on LinkedIn,